Education:     National Autonomous University of Mexico City, Mexico 1983 M.D.   Professional Experience: 1983-1984 Resident, General Pathology, National Institute of Nutrition, Mexico City, Mexico 1984-1985 Resident, Oncologic Pathology, National Institute of Cancerology, Mexico City, Mexico 1985-1986 Resident, Pediatric Pathology, National Institute of Pediatrics, Mexico City, Mexico 1988-1990 Postdoctoral Fellow, Pathology of Neurodegenerative Diseases, University of California San Diego, La Jolla, CA 1990-1991 Assistant Research Neuroscientist, University of California San Diego, La Jolla, CA 1991-1993 Assistant Professor, Departments of Neurosciences and Pathology, University of California San Diego, La Jolla, CA 1993-1996 Associate Professor, Departments of Neurosciences and Pathology, University of California San Diego, La Jolla, CA 1997-present Professor, Departments of Neurosciences and Pathology, University of California San Diego, La Jolla, CA 1995-present Director of Autopsy Service, Department of Pathology, University of California San Diego Medical Center, San Diego, California Honors: 1989 Weil Award (Honorable Mention), American Association of Neuropathologists 1990 Alzheimer Association/George F. Berlinger Faculty Scholar Award Neil Award (Honorable Mention), American Association of Neuropathologists Recent Publications: Link to PUB MED Results Masliah E, Hansen L, Adame A, Crews L, Bard F, Lee C, Seubert P, Games D, Kirby L, Schenk D. Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease.  Neurology. 64:129-31, 2005. Rockenstein E, Adame A, Mante M, Larrea G, Crews L, Windisch M, Moessler H, Masliah E. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer's disease with the neurotrophic compound Cerebrolysintrade mark. J Neural Transm. 112:269-82, 2005. Ho GJ, Hashimoto M, Adame A, Izu M, Alford MF, Thal LJ, Hansen LA, Masliah E. Altered p59(Fyn) kinase expression accompanies disease progression in Alzheimer's disease: implications for its functional role. Neurobiol Aging. 26:625-35, 2005. Langford D, Hurford R, Hashimoto M, Digicaylioglu M, Masliah E. Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120. BMC Neurosci. 6:8, 2005. Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, Mante M, Pfragner R, Schreiner E, Windisch M, Masliah E. Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein. J Neurosci Res. 80:247-59, 2005. Masliah E, Rockenstein E, Adame A, Alford M, Crews L, Hashimoto M, Lee M, Chilcote T, Games D, Schenck D. Effects of α-synuclein immunizations in a mouse model of Parkinson’s disease. Neuron. 46:857-68, 2005. Rockenstin E, Mante M, Alford M, Adame A, Crews L, Hashimoto M, Maya S, Esposito L, Mucke L, Masliah E.  High β-secretase activity elicits neurodegeneration in transgenic mice and despite reductions in amyloid-β levels: implications for the treatment of Alzheimer’s Disease. J. Biol. Chem. 280:32957-67, 2005 Singer O, Marr R, Rockenstein E, Crews L, Gage F, Verma I, Masliah E. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.. Nature Neuroscience. 2005 8:1343-9, 2005